FP7 Cooperation Work Programme: Health
Die Ausschreibung zum 7. Rahmenprogramm der EU enthält u.a. auch eine Rubrik zur Förderung von seltenen Erkrankungen (2.4.4 Rare diseases).
Auszug: HEALTH-2009-2.4.4-2: Preclinical development of substances with a clear potential as orphan drugs. FP7-HEALTH-2009-single stage. Support will be provided to preclinical studies (pharmacological, pharmacokinetics and toxicological) of EU designated orphan medicinal products. Involvement of industry is strongly recommended. Cancer therapies will not be considered. The orphan medicinal product will need to be granted the EU orphan designation at the latest on the date of the call closure. Funding scheme: Collaborative Project (small or medium-scale focused research project).
Deadline for single-stage submission and evaluation: 3 December 2008
Weitere Informationen unter http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite.FP7DetailsCallPage&call_id=140
